418 related articles for article (PubMed ID: 25442074)
1. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
Lake SL; Coupland SE; Taktak AF; Damato BE
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
[TBL] [Abstract][Full Text] [Related]
3. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.
Ewens KG; Kanetsky PA; Richards-Yutz J; Al-Dahmash S; De Luca MC; Bianciotto CG; Shields CL; Ganguly A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5721-9. PubMed ID: 23821189
[TBL] [Abstract][Full Text] [Related]
4. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
[TBL] [Abstract][Full Text] [Related]
5. [Genomic techniques used in uveal melanoma: a literature review].
Abi-Ayad N; Kodjikian L; Couturier J
J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
[TBL] [Abstract][Full Text] [Related]
6. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization analysis of archival formalin-fixed paraffin-embedded uveal melanomas.
Ghazvini S; Char DH; Kroll S; Waldman FM; Pinkel D
Cancer Genet Cytogenet; 1996 Sep; 90(2):95-101. PubMed ID: 8830715
[TBL] [Abstract][Full Text] [Related]
8. The utility and limitation of single nucleotide polymorphism analysis on whole genome amplified mesenchymal tumour DNA in formalin fixed tumour samples.
Liang CW; Lee YS; Marino-Enriquez A; Tsui K; Huang SH
Pathology; 2012 Jan; 44(1):33-41. PubMed ID: 22157688
[TBL] [Abstract][Full Text] [Related]
9. Genomic identification of significant targets in ciliochoroidal melanoma.
McCannel TA; Burgess BL; Nelson SF; Eskin A; Straatsma BR
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3018-22. PubMed ID: 20688739
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of chromogenic in situ hybridization for the determination of monosomy 3 in uveal melanoma.
Gleeson G; Larkin A; Horgan N; Kennedy S
Arch Pathol Lab Med; 2014 May; 138(5):664-70. PubMed ID: 24786124
[TBL] [Abstract][Full Text] [Related]
11. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.
Trolet J; Hupé P; Huon I; Lebigot I; Decraene C; Delattre O; Sastre-Garau X; Saule S; Thiéry JP; Plancher C; Asselain B; Desjardins L; Mariani P; Piperno-Neumann S; Barillot E; Couturier J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2572-80. PubMed ID: 19151381
[TBL] [Abstract][Full Text] [Related]
13. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
[TBL] [Abstract][Full Text] [Related]
15. Molecular karyotyping for detection of prognostic markers in fine needle aspiration biopsy samples of uveal melanoma.
Ganguly A; Richards-Yutz J; Ewens KG
Methods Mol Biol; 2014; 1102():441-58. PubMed ID: 24258992
[TBL] [Abstract][Full Text] [Related]
16. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
17. High-Resolution Array CGH Analysis Identifies Regional Deletions and Amplifications of Chromosome 8 in Uveal Melanoma.
Hammond DW; Al-Shammari NS; Danson S; Jacques R; Rennie IG; Sisley K
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3460-6. PubMed ID: 26030101
[TBL] [Abstract][Full Text] [Related]
18. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
[TBL] [Abstract][Full Text] [Related]
19. DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma.
Ehlers JP; Worley L; Onken MD; Harbour JW
Clin Cancer Res; 2005 May; 11(10):3609-13. PubMed ID: 15897555
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.
White JS; Becker RL; McLean IW; Director-Myska AE; Nath J
Cancer Genet Cytogenet; 2006 Jul; 168(1):11-21. PubMed ID: 16772116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
